Advertisement
Research Article

Differential Ligand Binding to a Human Cytomegalovirus Chemokine Receptor Determines Cell Type–Specific Motility

  • Jennifer Vomaske,

    Affiliation: Department of Molecular Microbiology and Immunology and The Vaccine and Gene Therapy Institute, Oregon Health & Science University, Portland, Oregon, United States of America

    X
  • Ryan M. Melnychuk,

    Affiliation: Department of Molecular Microbiology and Immunology and The Vaccine and Gene Therapy Institute, Oregon Health & Science University, Portland, Oregon, United States of America

    X
  • Patricia P. Smith,

    Affiliation: Department of Molecular Microbiology and Immunology and The Vaccine and Gene Therapy Institute, Oregon Health & Science University, Portland, Oregon, United States of America

    X
  • Joshua Powell,

    Affiliation: Department of Molecular Microbiology and Immunology and The Vaccine and Gene Therapy Institute, Oregon Health & Science University, Portland, Oregon, United States of America

    X
  • Laurel Hall,

    Affiliation: Department of Molecular Microbiology and Immunology and The Vaccine and Gene Therapy Institute, Oregon Health & Science University, Portland, Oregon, United States of America

    X
  • Victor DeFilippis,

    Affiliation: Department of Molecular Microbiology and Immunology and The Vaccine and Gene Therapy Institute, Oregon Health & Science University, Portland, Oregon, United States of America

    X
  • Klaus Früh,

    Affiliation: Department of Molecular Microbiology and Immunology and The Vaccine and Gene Therapy Institute, Oregon Health & Science University, Portland, Oregon, United States of America

    X
  • Martine Smit,

    Affiliation: Leiden/Amsterdam Center for Drug Research, Division of Medicinal Chemistry, Faculty of Chemistry, Amsterdam, The Netherlands

    X
  • David D. Schlaepfer,

    Affiliation: Department of Immunology, The Scripps Research Institute, La Jolla, California, United States of America

    X
  • Jay A. Nelson,

    Affiliation: Department of Molecular Microbiology and Immunology and The Vaccine and Gene Therapy Institute, Oregon Health & Science University, Portland, Oregon, United States of America

    X
  • Daniel N. Streblow mail

    streblow@ohsu.edu

    Affiliation: Department of Molecular Microbiology and Immunology and The Vaccine and Gene Therapy Institute, Oregon Health & Science University, Portland, Oregon, United States of America

    X
  • Published: February 20, 2009
  • DOI: 10.1371/journal.ppat.1000304

Media Coverage of this Article

Found additional news media or blog coverage for the article? Please let us know.